http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007178124-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56b349c10a8bb7f142a2d3de830114a5
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-204
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2007-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33d75ad28efc3e9877ededcf2e607544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4d0eaf41551a723a8cbc68ee4209692
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cfbe654d4e389615f2a9532f3d1bec0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c22d3c08bf222b63bf75c75b206827d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff7fe26b39e02a733111779a58e58226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21d97762a15c055346ec13a28394d076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa6b6abbd52f334d59f4c001bae83ca2
publicationDate 2007-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2007178124-A1
titleOfInvention Inorganic phosphates reversibly grafted with bioactive compounds and a method of their preparation
abstract Biologically active solid systems are disclosed, containing immobilized organic compounds, such as medicines, in the form of materials appropriate as bone fillers, implant coatings or other alike systems, of the common formula B—P-A, where B is an inorganic support consisting of calcium phosphate, calcium hydroxyphosphate (hydroxyapatite), their mixture, or some other biocompatible mixture containing these or other insoluble inorganic phosphates, —P— is a phosphoryl group —P—O—, and A is the residue of the immobilized, organic, biologically active compound, such as a medicine, containing unprotonated amine and/or hydroxide group(s), and a method of their preparation consisting of the treatment of inorganic phosphate with a grafting reagent and consequent reaction with organic compound. As a grafting reagent, phosphorus pentachloride is applied and all operations are completed in an aprotic solvent. The advantage of the above product is the extension of the time duration of release of the immobilized organic compound such as a medicine from the surface, the release of the organic compound in its initial, unaltered, fully biologically active form, in the absence of any toxic or alien side products of hydrolytic decomposition of the immobilized system.
priorityDate 2006-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005238684-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129215763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66553151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454118689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID589711
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21947193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148547704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22260040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410534866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129119613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451245303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128585769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57134040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413550331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450299265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452135712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663979
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226459332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226606878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226900985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411294575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127817167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129653859
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21881112

Total number of triples: 71.